首页 社会内容详情
telegram中文群组搜索(www.tel8.vip):Sanofi ends cancer drug trials

telegram中文群组搜索(www.tel8.vip):Sanofi ends cancer drug trials

分类:社会

网址:

SEO查询: 爱站网 站长工具

点击直达

telegram中文群组搜索www.tel8.vip)是一个Telegram群组分享平台。telegram中文群组搜索包括telegram中文群组搜索、telegram群组索引、Telegram群组导航、新加坡telegram群组、telegram中文群组、telegram群组(其他)、Telegram 美国 群组、telegram群组爬虫、电报群 科学上网、小飞机 怎么 加 群、tg群等内容。telegram中文群组搜索为广大电报用户提供各种电报群组/电报频道/电报机器人导航服务。

The decision to stop all studies with amcenestrant follows an analysis of late-stage trial data evaluating the drug in patients with a type of breast cancer, the company said in a statement yesterday.

PARIS: Sanofi is ending development of a key cancer medicine in a blow to the French drugmaker’s pipeline of experimental therapies.

The decision to stop all studies with amcenestrant follows an analysis of late-stage trial data evaluating the drug in patients with a type of breast cancer, the company said in a statement yesterday.

The move leaves Sanofi even more dependent for growth on blockbuster Dupixent, an antibody treatment for ailments ranging from asthma to severe eczema.

The company’s slate of experimental medicines has faced other setbacks, including safety concerns regarding multiple sclerosis treatment tolebrutinib.

,

新2足球贴士网www.hgbbs.vip)是国内最权威的足球赛事报道、预测平台。免费提供赛事直播,免费足球贴士,免费足球推介,免费专家贴士,免费足球推荐,最专业的足球心水网。

,

Sanofi has included both amcenestrant and tolebrutinib as among six products in its pipeline that it prioritised as “potentially transformative” treatments.

Some investors are questioning the company’s growth trajectory after both of those medicines encountered problems.

UBS analysts last week downgraded Sanofi, saying there are few major catalysts coming soon to drive more excitement to the stock. — Bloomberg


转载说明:本文转载自Sunbet。
  • 免费足球贴士(www.hgbbs.vip) @回复Ta

    2022-09-04 00:02:02 

    白天还艳阳高照,晚上就大风大雨下冰雹。3月16日晚8点过,受弱冷空气活动影响,成都平原多个区县遭受冰雹和暴雨袭击。3月17日,四川农村日报全媒体记者兵分多路,持续关注这场极端天气给农业生产带来的影响。闲下来看

发布评论